272 related articles for article (PubMed ID: 16964989)
1. Intravenous esmolol is well tolerated in elderly patients with heart failure in the early phase of non-ST elevation myocardial infarction.
Koutouzis M; Nikolidakis S; Grigoriadis A; Koutsogeorgis D; Kyriakides ZS
Drugs Aging; 2006; 23(8):673-80. PubMed ID: 16964989
[TBL] [Abstract][Full Text] [Related]
2. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
[TBL] [Abstract][Full Text] [Related]
3. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy.
Kirshenbaum JM; Kloner RF; McGowan N; Antman EM
J Am Coll Cardiol; 1988 Sep; 12(3):773-80. PubMed ID: 2900259
[TBL] [Abstract][Full Text] [Related]
4. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM
J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148
[TBL] [Abstract][Full Text] [Related]
5. The use of esmolol in whole-body hyperthermia: cardiovascular effects.
Berry JM; Michalsen A; Nagle V; Bull JM
Int J Hyperthermia; 1997; 13(3):261-8. PubMed ID: 9222810
[TBL] [Abstract][Full Text] [Related]
6. Comparison of esmolol and nitroprusside for acute post-cardiac surgical hypertension.
Gray RJ; Bateman TM; Czer LS; Conklin C; Matloff JM
Am J Cardiol; 1987 Apr; 59(8):887-91. PubMed ID: 2881481
[TBL] [Abstract][Full Text] [Related]
7. Acute hemodynamic effects of beta-blockers in patients with severe congestive heart failure: comparison of celiprolol and esmolol.
Felix SB; Stangl V; Kieback A; Doerffel W; Staudt A; Wernecke KD; Baumann G; Stangl K
J Cardiovasc Pharmacol; 2001 Nov; 38(5):666-71. PubMed ID: 11602813
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
Sung RJ; Blanski L; Kirshenbaum J; MacCosbe P; Turlapaty P; Laddu AR
J Clin Pharmacol; 1986 Mar; 26(S1):A15-A26. PubMed ID: 2870082
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic and hemodynamic recovery following dobutamine stress echo: benefit of low-dose esmolol administration.
Abdullah EE; Pollick C
Int J Card Imaging; 1997 Feb; 13(1):53-7. PubMed ID: 9080239
[TBL] [Abstract][Full Text] [Related]
10. A new dosing regimen for esmolol to treat supraventricular tachyarrhythmia in Chinese patients.
Ko WJ; Chu SH
J Am Coll Cardiol; 1994 Feb; 23(2):302-6. PubMed ID: 7905013
[TBL] [Abstract][Full Text] [Related]
11. Esmolol in acute ischemic syndromes.
Mitchell RG; Stoddard MF; Ben-Yehuda O; Aggarwal KB; Allenby KS; Trillo RA; Loyd R; Chang CT; Labovitz AJ
Am Heart J; 2002 Nov; 144(5):E9. PubMed ID: 12422138
[TBL] [Abstract][Full Text] [Related]
12. Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
Mattioli G; Ricci S; Rigo R; Fusaro MT; Cappello C
Postgrad Med J; 1986; 62 Suppl 1():164-6. PubMed ID: 3534855
[TBL] [Abstract][Full Text] [Related]
13. Effects of esmolol on patients with left ventricular dysfunction.
Iskandrian AS; Bemis CE; Hakki AH; Panidis I; Heo J; Toole JG; Hua TA; Allin D; Kane-Marsch S
J Am Coll Cardiol; 1986 Jul; 8(1):225-31. PubMed ID: 2872244
[TBL] [Abstract][Full Text] [Related]
14. Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia.
Kirshenbaum JM; Kloner RA; Antman EM; Braunwald E
Circulation; 1985 Oct; 72(4):873-80. PubMed ID: 2863013
[TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of esmolol during myocardial revascularization.
Girard D; Shulman BJ; Thys DM; Mindich BP; Mikula SK; Kaplan JA
Anesthesiology; 1986 Aug; 65(2):157-64. PubMed ID: 3526984
[TBL] [Abstract][Full Text] [Related]
16. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK
Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069
[TBL] [Abstract][Full Text] [Related]
17. [The use of esmolol in patients with myocardial infarction complicated with acute left ventricular failure].
Tereshchenko SN; Kositsyna IV; Dzhaiani NA; Golubev AV; Kochetov AG
Kardiologiia; 2005; 45(6):19-22. PubMed ID: 16007029
[TBL] [Abstract][Full Text] [Related]
18. [Acute hemodynamic effects of intravenous recombinant human brain natriuretic peptide in patients with acute myocardial infarction complicated with heart failure].
Li SQ; Fu XH; Liu J; Gu XS; Zhang J; Fan XN; Jiang YF; Miao Q
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):23-7. PubMed ID: 16626544
[TBL] [Abstract][Full Text] [Related]
19. Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients.
Suttner S; Boldt J; Mengistu A; Lang K; Mayer J
Br J Anaesth; 2009 May; 102(5):597-607. PubMed ID: 19336536
[TBL] [Abstract][Full Text] [Related]
20. The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery.
Kurian SM; Evans R; Fernandes NO; Sherry KM
Anaesthesia; 2001 Dec; 56(12):1163-8. PubMed ID: 11736772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
